Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Zelira Therapeutics Ltd (PK)
ZLDAF
Healthcare
Biotechnology
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops ZENIVOL, a cannabinoid drug for the treatment...
of chronic insomnia. The company also provides over the counter (OTC) products, including SprinJeneCBD, an oral care product; and acne treatment products under the RAF FIVE name, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. In addition, it offers products for autism and chronic noncancer pain. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is based in Perth, Australia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (PINL:ZLDAF)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
mrdoobee
X
Post by
mrdoobee
on Dec 05, 2018 4:51pm
SUDA ENTERS AGREEMENT WITH AUSTRALIAN CANNABIS COMPANY ZELDA
PERTH, AUSTRALIA Thursday 6th December 2018: SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery (“SUDA”), today announces that it has entered into a fully funded feasibility
...more
(0)
•••
gogetit
X
Post by
gogetit
on Mar 19, 2018 3:19pm
Zelda
see some news here: https://www.proactiveinvestors.com.au/companies/news/187935/zelda-therapeutics-approved-for-australias-first-medicinal-cannabis-trial-targeting-insomnia-187935.html
Sky Gold Engages Drill Company for Upcoming Program on Its Evening Star Property, Walker Lane Trend, Nevada
posted Mar 16, 2026 9:00am by
Sky Gold Corp.
-
|
Mike England, CEO of Sky Gold Corp. states: "We are very excited to get drilling again at Evening Star, this time backed with new geophysical data as well as recently uncovered coordinates from a wildcat hole drilled in 1970 that reported 0.22% Cu, 3.24% Pb, 1.41% Zn and 76 g/t Ag over 166 metres*." ...read more
(0)
•••
100million4me
X
Post by
100million4me
on Mar 14, 2018 9:48pm
Hellooo
Anybody following this?
(2)
•••
lbell
X
Post by
lbell
on Jan 10, 2018 11:26pm
Short interest decreased by 74.6%
ZELDA THERAPEUTICS LTD ORD AUSTR (OTCMKTS:ZLDAF) Just Reported Decreased Shorts January 10, 2018 - By Richard Conner The stock of ZELDA THERAPEUTICS LTD ORD AUSTR (OTCMKTS:ZLDAF
...more
(0)
•••
zenrush
X
Post by
zenrush
on Jun 01, 2017 11:44pm
great opportunity
https://www.facebook.com/pg/PlayersNetworkPNTV/posts/?ref=page_internal
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Mobix Labs lands U.S. Navy Tomahawk missile component order
A gold and silver stock turning milestones into momentum
Podcasts